FDA campaign F-1144-2024
Class IIIHazard
During an inspection by NCDA, the firm was notified that the product label fails to list any ingredients.
Distribution
Products were shipped to the following states: GA, NC & SC
REKALLD area-alert coverage: GA, NC, SC (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.